Search Results

Imatinib Mesylate 500 mg  | 99.73%

TargetMol

Imatinib mesylate is a tyrosine kinase receptor inhibitor with antineoplastic activity (IC50s: 0.6 μM, 0.1 μM and 0.1 μM for v-Abl, c-Kit and PDGFR, respectively).

More Information Supplier Page

Imatinib Mesylate 200 mg  | 99.73%

TargetMol

Imatinib mesylate is a tyrosine kinase receptor inhibitor with antineoplastic activity (IC50s: 0.6 μM, 0.1 μM and 0.1 μM for v-Abl, c-Kit and PDGFR, respectively).

More Information Supplier Page

Mestranol 200 mg  | Purity Not Available

TargetMol

Mestranol, a semisynthetic estrogen, is used as an estrogen receptor agonist and must be demethylated to be biologically active.

More Information Supplier Page